Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Salestools Logo

Salestools

L'agent IA #1 pour les équipes de vente et Go-to-Market. Vendez plus, plus vite, avec moins d'effort.

Produit

  • Agents de vente IA
  • Données d'intention
  • Données technologiques
  • Suivi des visiteurs
  • Copilote
  • Vente sociale

Solutions

  • Service client
  • E-commerce
  • SaaS
  • Entreprise
  • Petite entreprise

Ressources

  • Le rapport
  • Documentation
  • Référence API
  • Centre d'aide
  • Blog
  • Études de cas
  • Webinaires

Entreprise

  • À propos
  • Carrières
  • Presse
  • Contact
  • Partenaires

Nos bureaux

  • New York, HQ
  • Bucarest, Laboratoire de recherche IA
  • Zug, Suisse

© 2025 Salestools. Tous droits réservés.

Conditions relatives aux données et sécuritéPolitique de confidentialitéConditions de service
Tous les systèmes opérationnels
Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Back to The Report
Fundraising

Guardant Health

Guardant Health Raises $360M in Series F

2012
Founded
1400+
Employees
505 Penobscot Drive, Redwood City, CA 94063
Updated May 19, 2024
2 min read

Quick Facts

Guardant Health Raises $360M in Series F


Guardant Health has successfully raised $360M in a Series F at a $12B valuation led by SoftBank Vision Fund, Baillie Gifford, T. Rowe Price, Khosla Ventures, Sequoia Capital.


Company Overview


Guardant Health is a Biotech company headquartered in 505 Penobscot Drive, Redwood City, CA 94063, founded in 2012 with 1400+ employees.


Liquid biopsy cancer detection


Fundraising Details


  • Amount Raised: $360M
  • Round Type: Series F
  • Valuation: $12B
  • Date: 2024-05-19
  • Investors: SoftBank Vision Fund, Baillie Gifford, T. Rowe Price, Khosla Ventures, Sequoia Capital

About Guardant Health


Liquid biopsy cancer detection The company is positioned in the Biotech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 505 Penobscot Drive, Redwood City, CA 94063
  • Founded: 2012
  • Team Size: 1400+
  • Industry: Biotech

What This Means


This funding round demonstrates strong investor confidence in Guardant Health's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Guardant Health's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $12B valuation marks an important milestone for Guardant Health, positioning the company among notable players in the Biotech industry.


Looking Ahead


With this new capital, Guardant Health is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-05-19. For more information about Guardant Health, visit their headquarters at 505 Penobscot Drive, Redwood City, CA 94063.

Topics

Fundraising(2912)BiotechSeries FGuardant Health

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million